<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The etiology and genetic susceptibility of <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya</z:e> <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">angiopathy</z:e> (<z:chebi fb="0" ids="34840">MMA</z:chebi>) (<z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya disease</z:e>, <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya syndrome</z:e> and unilateral type of <z:chebi fb="0" ids="34840">MMA</z:chebi>) still remain unclear </plain></SENT>
<SENT sid="1" pm="."><plain>In Asian patient cohorts several HLA markers were described to be associated with <z:chebi fb="0" ids="34840">MMA</z:chebi>, but in Caucasians very little is known about genetic susceptibility of this <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">angiopathy</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHOD: We analysed DNA of 33 Caucasian patients with <z:chebi fb="0" ids="34840">MMA</z:chebi> for HLA-A, HLA-B, HLA-DRB1, and HLA-DQB1 markers, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>HLA frequencies of <z:hpo ids='HP_0000001'>all</z:hpo> 33 patients with <z:chebi fb="0" ids="34840">MMA</z:chebi> were compared with HLA-frequencies of Caucasian controls </plain></SENT>
<SENT sid="4" pm="."><plain>Additionally, subgroup analysis of 22 patients with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya disease</z:e> (MMD) and 11 patients with unilateral type of <z:chebi fb="0" ids="34840">MMA</z:chebi> was performed </plain></SENT>
<SENT sid="5" pm="."><plain>FINDINGS: Significant association was observed for HLA-DRB1*03 and HLA-DRB1*13 in <z:hpo ids='HP_0000001'>all</z:hpo> 33 patients (P (c) &lt; 0.001 and P (c) &lt; 0.001, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, HLA-A*02 (P (c) = 0.009); HLA-B*08 (P (c) = 0.009), and HLA-DQB1*03 (P (c) = 0.003) frequencies were higher in <z:hpo ids='HP_0000001'>all</z:hpo> patients with <z:chebi fb="0" ids="34840">MMA</z:chebi> when compared with the controls </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, in 22 patients with MMD a higher frequency of HLA-DRB1*03 (P (c) &lt; 0.001) was observed when compared with controls </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The results of this study indicate a putative association of HLA markers with <z:chebi fb="0" ids="34840">MMA</z:chebi> in Caucasian patients </plain></SENT>
<SENT sid="9" pm="."><plain>Further studies are needed to elucidate the role of human MHC in the pathogenesis of this <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">angiopathy</z:e> </plain></SENT>
</text></document>